ST. LOUIS — Consumers are suing pharmaceutical companies, citing alleged product liability and breach of implied warranty.

Annie Averhart, Kristen Boatmen, Clyde Brown Jr., Goldia Earls, et al. filed a complaint June 15 in the St. Louis 22nd Judicial Circuit Court against AstraZeneca Pharmaceuticals, Takeda Pharmaceuticals, Pfizer Inc., the Procter & Gamble Co., et al, alleging that the defendants failed to adequately inform consumers and the prescribing medical community about the magnified risk of kidney injuries related to the use of Prilosec and Nexium (PPIs).

According to the complaint, since 2003, the defendants' Prilosee and Nexium (PPIs) have been among the top 10 best-selling and most dispensed form of prescription medication in the United States each year. The plaintiffs claim that researchers at the Yale School of Medicine conducted an examination of these products and found that the use of PPI resulted in acute interstitial nephritis and left most patients with some level of chronic kidney disease. 

The plaintiffs hold the defendants responsible because they allegedly failed to provide consistent labeling regarding the risks of the products, failed to use reasonable care when advertising and promoting PPIs, and failed to warn the public of the side effects of the product.

The plaintiffs request a trial by jury and seek judgment of actual damages in excess of $25,000, plus costs incurred and all such other and further relief as the court deems proper. They are represented by Jeffrey J. Lowe, James J. Rosemergy and Sarah Shoemake Doles of Carey Danis & Lowe in St. Louis.

St. Louis 22nd Judicial Circuit Court Case number 1722-CC09811

Want to get notified whenever we write about St. Louis 22nd Judicial Circuit Court ?
Next time we write about St. Louis 22nd Judicial Circuit Court, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

St. Louis 22nd Judicial Circuit Court

More News